Orange Book product · Generic (ANDA)
AMINOCAPROIC ACID
AMINOCAPROIC ACID
At a glance
Mar 24, 2023
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 24, 2023
3 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
AMINOCAPROIC ACID
Strength
0.25GM/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 214458
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMINOCAPROIC ACID
- 2004AMICARBrand (NDA)
NDA 015197 · HIKMA
- 1982AMINOCAPROIC ACIDBrand (NDA)
NDA 018590 · BAXTER HLTHCARE
- —AMICARBrand (NDA)
NDA 015229 · EPIC PHARMA LLC
- —AMICARBrand (NDA)
NDA 015230 · HIKMA
- 2025AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 215374 · ZENARA
- 2025AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213216 · SCIEGEN PHARMS
- 2024AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 215100 · MSN
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213213 · SUNNY
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 212938 · MSN
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 216464 · ANNORA PHARMA
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 216804 · AUROBINDO PHARMA
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213944 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
